FEATURED ARTICLES
How The FDA, MHRA, & EMA Differ On Externally Controlled Trials
As the FDA, MHRA, and EMA release draft frameworks on externally controlled trials, sponsors face differing expectations. The U.K. leans pragmatic, the U.S. remains cautious, and Europe’s guidance is still evolving — leaving global trial planners to navigate regulatory gray zones.
-
![beroe_raredisease2]( "Trends In Rare Disease Trials: Evaluating Trial Types' Pros, Cons, And Adoption Rates")
Trends In Rare Disease Trials: Evaluating Trial Types' Pros, Cons, And Adoption RatesIn the second article of the series, Beroe Inc. Lead Analyst Sapna Rani provides a comprehensive evaluation of leading trial types for rare disease development and compares adoption rates, design-specific trade-offs, and practical selection criteria.
-
![beroe_raredisease1]( "Trends In Rare Disease Trials: Trial Designs, Challenges, And Regulatory Progress")
Trends In Rare Disease Trials: Trial Designs, Challenges, And Regulatory ProgressBeroe Inc. Lead Analyst Sapan Rani unpacks the evolution of trial design types in rare disease research, analyzes ongoing challenges, and examines how regulatory support is enabling innovation in part one of this three-part series.
-
![Doctor with hospital management-GettyImages-1130406795]( "Oncology PI Shares Lessons Learned And Successes Working With Basic Scientists")
Oncology PI Shares Lessons Learned And Successes Working With Basic ScientistsRanee Mehra, MD, shares her successes and discusses how they shape her approach to future research, as well as details the importance of working closely with basic scientists.
SERVICES & PRODUCTS
As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC Services
Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.
Experience customized and validated flow cytometry (FCM) biomarkers and panels for your clinical research on a global scale. Learn how FCM can enhance your research and help develop the panels you need.